Articles related to PREVENTIVE MEDICINE

Atorvastatin reduced major cardiovascular events among adults aged 70 years and older without known cardiovascular disease, diabetes, or dementia, but the benefit did not translate into a statistically significant improvement in disability-free survival over nearly six years of follow-up.

Self-reported cannabis use in the United States increased substantially between 2008 and 2022, with particularly pronounced growth in daily or near-daily consumption, while high-frequency alcohol use remained stable or declined during the same period.

The FDA approved Moderna’s mFLUSIVA, the first mRNA influenza vaccine, for adults aged 50 and older. Availability is expected during the 2026–2027 respiratory virus season, with confirmatory evidence pending for adults 65 and older.

Three-year increases or sustained elevations in NT-proBNP were associated with greater cardiovascular and mortality risks among older adults without prior cardiovascular disease. Participants whose elevations resolved had risks resembling those who remained free of heart stress.

Emerging evidence suggests the sodium-to-potassium ratio may better reflect cardiovascular risk than sodium intake alone. Experts emphasized that increasing dietary potassium alongside sodium reduction may support blood pressure control, while acknowledging important safety considerations for select patient populations.

Discontinuing statins in adults 75 years and older without prior cardiovascular disease did not increase mortality or major cardiovascular events over three years in a randomized trial. LDL cholesterol rose substantially after discontinuation, and longer-term effects remain uncertain.